Concourse Financial Group Securities, Inc. Seagen Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$191.51 - $216.16 $191 - $216	-1 Reduced 9.09%	10 $2,000
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $1,688 - $1,856	9 Added 450.0%	11 $2,000
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $182,326 - $290,201	-1,429 Reduced 99.86%	2 $0
Q4 2022 Jan 30, 2023	BUY	$117.37 - $139.17 $24,060 - $28,529	205 Added 16.72%	1,431 $0
Q3 2022 Nov 15, 2022	SELL	$135.27 - $180.11 $135 - $180	-1 Reduced 0.08%	1,226 $168,000
Q2 2022 Aug 09, 2022	SELL	$108.81 - $179.33 $196,946 - $324,587	-1,810 Reduced 59.6%	1,227 $217,000
Q1 2022 May 09, 2022	SELL	$119.61 - $157.85 $270,677 - $357,214	-2,263 Reduced 42.7%	3,037 $437,000
Q4 2021 Feb 07, 2022	BUY	$142.57 - $190.86 $89,106 - $119,287	625 Added 13.37%	5,300 $819,000
Q3 2021 Nov 09, 2021	BUY	$142.45 - $169.82 $89,743 - $106,986	630 Added 15.57%	4,675 $794,000
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $131,567 - $156,911	974 Added 31.72%	4,045 $638,000
Q1 2021 May 13, 2021	BUY	$137.51 - $190.8 $415,005 - $575,834	3,018 Added 5694.34%	3,071 $426,000
Q4 2020 Feb 02, 2021	BUY	$164.63 - $211.93 $8,725 - $11,232	53 New	53 $9,000

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account